PrimeRFP SCOUT · Federal Contract Recompete Brief

36C25723C0090 — RADIOPHARMACEUTICALS

RADIOPHARMACEUTICALS is a federal NONE award for Department of Veterans Affairs (VA) held by AUSTIN NUCLEAR PHARMACY SERVICES LLC. Estimated value $3.5M ($700K obligated). Current period of performance ends Aug 8, 2024 (potential Aug 8, 2028). Last award drew 3 bidders. Place of performance: TEMPLE TX. Related solicitation 36C25723Q0719.

$3.5M
Estimated Value
$700K
Obligated
Aug 8, 2024
PoP End / Expires
3
Bidders (last award)

Track this contract

Get an alert when the recompete window opens, the incumbent changes, or a protest lands. One email, no account.

See related expiring contracts →

Analysis

Public

AUSTIN NUCLEAR PHARMACY SERVICES LLC holds $102K across 2 federal awards, concentrated at Department of Defense (DOD). Competition previously drew 3 offers. Set-aside status: NONE. PoP ended Aug 8, 2024 — the usual 12–18 month planning window is closed; recompete action looks late or overdue.

Contract facts

NONE
Contract number36C25723C0090
AgencyDepartment of Veterans Affairs (VA)
IncumbentAUSTIN NUCLEAR PHARMACY SERVICES LLC
CAGE8VU74
UEIXXNZCY4XT3X5
NAICS325412

No full NAICS 325412 intel page yet. Browse NAICS intelligence

PSC6505
Place of performanceTEMPLE TX
Pricing typeFirm Fixed Price
Extent competedFull And Open Competition
Related solicitation36C25723Q0719
PoP startAug 9, 2023
PoP end (current)Aug 8, 2024
PoP end (w/ options)Aug 8, 2028
Obligated$700K
Current value$700K
Potential value$3.5M

Recompete timing

Public
Past PoP end (742 days ago)

Current PoP ended Aug 8, 2024 (742 days ago). The usual 12–18 month agency planning window is closed — recompete action looks late / overdue relative to a normal cycle. Watch for bridge orders, follow-ons, or a new solicitation.

Watch this contract — one email →

Incumbent footprint

Public record

AUSTIN NUCLEAR PHARMACY SERVICES LLC$102K obligated across 2 awards (firm-wide, all agencies) · lead buyer Department of Defense (DOD).

% of firm-wide obligated ($102K) · all agencies
Department of Defense (DOD)$53K · 52%Department of Veterans Affairs (VA)$49K · 48%
Open full company profile

Query this award live in SCOUT via MCP — personalized scoring, watchlists, and capture workflow across the corpus. Learn about SCOUT MCP

Track this contract

Get an alert when the recompete window opens, the incumbent changes, or a protest lands. One email, no account.

See the recompete window for 36C25723C0090
More in SCOUT
Track this contract →

Alert when the recompete window opens, the incumbent changes, or a protest lands. One email, no account.

Size up the competition →

See all live recompete landscapes — who else is expiring, and where the openings are.

Research the incumbent →

Open AUSTIN NUCLEAR PHARMACY SERVICES LLC’s federal contract profile — agency mix, recompete pipeline, and teaming relationships.

Frequently asked questions

What is contract 36C25723C0090?

36C25723C0090 (RADIOPHARMACEUTICALS) is a Department of Veterans Affairs (VA) award with an estimated value of $3.5M, currently held by AUSTIN NUCLEAR PHARMACY SERVICES LLC. Figures are USASpending-sourced public-record facts normalized by PrimeRFP SCOUT.

Who is the incumbent on 36C25723C0090?

AUSTIN NUCLEAR PHARMACY SERVICES LLC is the incumbent with $102K across 2 related awards in SCOUT’s public footprint. The current period of performance ends Aug 8, 2024.

When does 36C25723C0090 come up for recompete?

SCOUT tracks a period-of-performance end of Aug 8, 2024. Actual solicitation timing can shift with extensions, bridges, or consolidations.

Data: Showing contracts ≥ $100K from federal procurement records (FPDS-NG, SAM.gov, and related repositories), normalized by PrimeRFP SCOUT. Each row keyed by Award ID (PIID); task orders appear as independent rows. Explore it live — $90 Pilot →

Data as of · refreshed monthlyLatest procurement action
Sources: USASpending, FPDS, SAM.gov · Public-record facts + SCOUT analysis shown above; personalized scoring in SCOUT.
primerfp.com/intel/contract/36C25723C0090

SCOUT Signal

August 2026

One VA health contract was 35% of civilian federal obligations in July.

Meanwhile VA's service-disabled veteran-owned contract actions fell 41.8%. The same agency, the same month, the large-vendor lane expanding while the small-business lane contracted. Figures are civilian-agency obligations through 2026-07-31; DoD FPDS for this window is labeled incomplete.

This issue is the whole civilian market. Your capture plan isn't.

Read the August 2026 issue →